SEGMENTAL ANALYSIS Renishaw manages its operations in two segments, comprising metrology and healthcare products.
The results of these segments are regularly reviewed by the Board to allocate resources to segments and to assess their performance.
The Group evaluates performance of the segments on the basis of revenue and profits.
The revenue, depreciation and amortisation, and operating profit for each reportable segment was: Year ended 30th June 2010 Metrology Healthcare Total 000 000 000 Revenue 162,118 19,489 181,607 Depreciation and amortisation 12,725 1,745 14,470 Operating profit before exceptional item 31,537 3,442 28,095 Exceptional item - Impairment write-down 1,668 - 1,668 Share of profits from associates 479 - 479 Net financial income 151 Profit before tax 27,057 Year ended 30th June 2009 Metrology Healthcare Total 000 000 000 Revenue 152,894 18,353 171,247 Depreciation and amortisation 12,415 2,349 14,764 Operating profit before exceptional item 10,315 4,324 5,991 Exceptional item - Redundancy costs 3,808 313 4,121 Share of profits from associates 317 - 317 Net financial income 2,535 Profit before tax 4,722 There is no allocation of assets and liabilities to operating segments.
Depreciation is included within certain other overhead expenditure which is allocated to segments on the basis of the level of activity.
The analysis of revenue by geographical market was: 2010 2009 000 000 Far East 71,051 52,006 Continental Europe 52,147 63,222 North & South America 41,455 40,071 United Kingdom 10,650 11,259 Other regions 6,304 4,689 Total group revenue 181,607 171,247 Revenue in the above table has been allocated to regions based on the geographical location of the customer.
Individual countries which comprised more than 10% of group revenue were: 2009 2010 000 000 USA 35,381 34,795 China 34,211 19,458 Germany 28,385 23,042 Japan 20,946 19,552 There was no revenue from transactions with a single external customer amounting to 10% or more of the Groups total revenue.
